Portola Pharmaceuticals Inc. (PTLA) Drops 5.14% on January 06

Equities Staff |

Portola Pharmaceuticals Inc. (PTLA) was one of the Russell 2000's biggest losers for Wednesday January 06 as the stock slid 5.14% to $45.69, a loss of $-2.475 per share. Starting at an opening price of $47.12 a share, the stock traded between $45.67 and $48.50 over the course of the trading day. Volume was 240,840 shares over 2,709 trades, against an average daily volume of 516,575 shares and a total float of 52.71 million.

The losses send Portola Pharmaceuticals Inc. down to a market cap of $2.41 billion. In the last year, Portola Pharmaceuticals Inc. has traded between $57.96 and $26.26, and its 50-day SMA is currently $49.58 and 200-day SMA is $45.45.

Portola Pharmaceuticals Inc is a biopharmaceutical company. It develops & commercializes novel therapeutics in the areas of thrombosis, other hematologic disorders & inflammation for patients who currently have limited or no approved treatment options.

Portola Pharmaceuticals Inc. is based out of South San Francisco, CA and has some 70 employees. Its CEO is William Lis.

For a complete fundamental analysis analysis of Portola Pharmaceuticals Inc., check out Equities.com’s Stock Valuation Analysis report for PTLA. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Star Navigation Systems Group Ltd.

Star Navigation Systems Group Ltd is engaged in the development, marketing and promotion of in-flight safety monitoring systems.

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…


Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.